日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab

组织非特异性全基因组甲基化组富集检测方法的临床验证,用于监测帕博利珠单抗的疗效

Stutheit-Zhao, Eric Y; Zhong, Yongqi; Melton, Collin A; Lightbody, Elizabeth D; Hinterberg, Michael A; Wang, Yarong; Hall, Owen; Sosa, Eduardo V; Provance, Jeremy B; Zhang, Junjun; Licon, Abel; Liu, Zhihui Amy; Abdul Razak, Albiruni R; Spreafico, Anna; Bedard, Philippe L; Hansen, Aaron R; Lheureux, Stephanie; Ohashi, Pamela S; Williams, Alan; Bratman, Scott V; Allen, Brian A; Zhang, Jing; De Carvalho, Daniel D; Hartman, Anne-Renee; Siu, Lillian L; Sanz-Garcia, Enrique

Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study

肿瘤内注射INT230-6治疗晚期实体瘤成年患者的安全性和有效性:一项开放标签1/2期剂量递增研究的结果

Thomas, Jacob S; Siu, Lillian L; Ingham, Matthew; Azad, Nilofer S; Meyer, Christian F; Olszanski, Anthony J; Whalen, Giles F; Camacho, Luis H; Hu, James S; Hanna, Diana L; Cheng, Phillip M; Abdul Razak, Albiruni R; Abbate, Franco; Mahmood, Syed; Walters, Ian B; Bender, Lewis H; El-Khoueiry, Anthony B

Epidemiology, Treatment Patterns, Survival, Healthcare Resource Utilization, and Costs of Dedifferentiated Liposarcoma (DDLPS) in Canada: A Retrospective Cohort Study Using Administrative Databases in Ontario

加拿大去分化脂肪肉瘤 (DDLPS) 的流行病学、治疗模式、生存率、医疗资源利用情况和费用:一项基于安大略省行政数据库的回顾性队列研究

Seung, Soo Jin; Wong, Anisia; Milan, Raymond; Chandran, Nisha; Razak, Albiruni R Abdul

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Afamitresgene autoleucel 用于晚期滑膜肉瘤和黏液样圆形细胞脂肪肉瘤(SPEARHEAD-1):一项国际性、开放标签的 II 期试验

D'Angelo, Sandra P; Araujo, Dejka M; Abdul Razak, Albiruni R; Agulnik, Mark; Attia, Steven; Blay, Jean-Yves; Carrasco Garcia, Irene; Charlson, John A; Choy, Edwin; Demetri, George D; Druta, Mihaela; Forcade, Edouard; Ganjoo, Kristen N; Glod, John; Keedy, Vicki L; Le Cesne, Axel; Liebner, David A; Moreno, Victor; Pollack, Seth M; Schuetze, Scott M; Schwartz, Gary K; Strauss, Sandra J; Tap, William D; Thistlethwaite, Fiona; Valverde Morales, Claudia Maria; Wagner, Michael J; Wilky, Breelyn A; McAlpine, Cheryl; Hudson, Laura; Navenot, Jean-Marc; Wang, Tianjiao; Bai, Jane; Rafail, Stavros; Wang, Ruoxi; Sun, Amy; Fernandes, Lilliam; Van Winkle, Erin; Elefant, Erica; Lunt, Colin; Norry, Elliot; Williams, Dennis; Biswas, Swethajit; Van Tine, Brian A

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors

肿瘤初始状态下游离甲基化组和片段组的早期变化可预测帕博利珠单抗治疗实体瘤的预后

Stutheit-Zhao, Eric Y; Sanz-Garcia, Enrique; Liu, Zhihui Amy; Wong, Derek; Marsh, Kayla; Abdul Razak, Albiruni R; Spreafico, Anna; Bedard, Philippe L; Hansen, Aaron R; Lheureux, Stephanie; Torti, Dax; Lam, Bernard; Yang, Shih Yu Cindy; Burgener, Justin; Luo, Ping; Zeng, Yong; Cheng, Nicholas; Awadalla, Philip; Bratman, Scott V; Ohashi, Pamela S; Pugh, Trevor J; Siu, Lillian L

Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient

肿瘤反应性γδ T细胞有助于默克尔细胞癌患者对PD-1阻断疗法产生完全反应。

Scott C Lien ,Dalam Ly ,S Y Cindy Yang ,Ben X Wang ,Derek L Clouthier ,Michael St Paul ,Ramy Gadalla ,Babak Noamani ,Carlos R Garcia-Batres ,Sarah Boross-Harmer ,Philippe L Bedard ,Trevor J Pugh ,Anna Spreafico ,Naoto Hirano ,Albiruni R A Razak ,Pamela S Ohashi

Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data

多基因检测对晚期实体恶性肿瘤成本和疗效的影响:基于关联行政数据的成本效益分析

Hernando-Calvo, Alberto; Nguyen, Paul; Bedard, Philippe L; Chan, Kelvin K W; Saleh, Ramy R; Weymann, Deirdre; Yu, Celeste; Amir, Eitan; Regier, Dean A; Gyawali, Bishal; Kain, Danielle; Wilson, Brooke; Earle, Craig C; Mittmann, Nicole; Abdul Razak, Albiruni R; Isaranuwatchai, Wanrudee; Sabatini, Peter; Spreafico, Anna; Stockley, Tracy L; Pugh, Trevor J; Williams, Christine; Siu, Lillian L; Hanna, Timothy P

Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)

自身免疫面板作为免疫检查点抑制剂治疗患者毒性的预测指标(ALERT)

Genta, Sofia; Lajkosz, Katherine; Yee, Noelle R; Spiliopoulou, Pavlina; Heirali, Alya; Hansen, Aaron R; Siu, Lillian L; Saibil, Sam; Stayner, Lee-Anne; Yanekina, Maryia; Sauder, Maxwell B; Keshavarzi, Sareh; Salawu, Abdulazeez; Vornicova, Olga; Butler, Marcus O; Bedard, Philippe L; Razak, Albiruni R Abdul; Rottapel, Robert; Chruscinski, Andrzej; Coburn, Bryan; Spreafico, Anna

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

GSK3368715(一种 I 型 PRMT 抑制剂)治疗晚期实体瘤患者的 1 期研究

El-Khoueiry, Anthony B; Clarke, James; Neff, Tobias; Crossman, Tim; Ratia, Nirav; Rathi, Chetan; Noto, Paul; Tarkar, Aarti; Garrido-Laguna, Ignacio; Calvo, Emiliano; Rodón, Jordi; Tran, Ben; O'Dwyer, Peter J; Cuker, Adam; Abdul Razak, Albiruni R

A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

一项评估 Alpelisib 联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌患者的 1b/2 期研究

Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George Jr; Solomon, Benjamin; Lim, Darren Wan-Teck; Hong, Ruey-Long; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre